Latest News – PSNC Main site
Pharmaceutical Services Negotiating Committee
MHRA Company Led Drug Alert and Recall: Instanyl 100mcg nasal spray solution
CLDA number: CLDA (21)A/01 Date issued: 18th January 2021 The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a company-led drug recall for: Instanyl 100mcg nasal spray solution Product Batch number Expiry Date Pack Size First Distributed Instanyl 100mcg Nasal Spray 447055 31/10/2021 1 x 6 single dose containers 14/04/2020 Takeda UK Limited is...
PSNC Video Message from CEO Simon Dukes
PSNC Chief Executive Simon Dukes has recorded a new video message for community pharmacy contractors and their teams. In the video Simon reflects on the extraordinary year just passed and looks to the challenges ahead, noting in particular the stoicism and commitment of community pharmacy teams and calling for an end to the slow responses...
January 2021 Price Concessions 1st Update
The Department of Health and Social Care (DHSC) has today granted the following initial list of price concessions: Drug Pack Size Price Concession Ciprofloxacin 500mg tablets 10 £3.85 Duloxetine 20mg gastro-resistant capsules 28 £8.68 Duloxetine 30mg gastro-resistant capsules 28 £2.39 Duloxetine 60mg gastro-resistant capsules 28 £3.99 Enalapril 10mg tablets 28 £6.10 Enalapril 20mg tablets 28...
Discharge Medicines Service Toolkit published
NHS England and NHS Improvement (NHSE&I) have today (15th January 2021), published the NHS Discharge Medicines Service (DMS) Toolkit for Pharmacy Staff in Community, Primary and Secondary Care. The toolkit aims to assist and support cross sector implementation of the DMS as an Essential service in all NHS community pharmacies in England. It sets out...
Medicine Supply Notification: Sancuso (granisetron) 3.1mg/24 hours transdermal patches
Department of Health and Social Care (DHSC) has issued a Medicine Supply Notification (MSN) for Sancuso (granisetron) 3.1mg/24 hours transdermal patches Sancuso® (granisetron) 3.1mg/24 hours transdermal patches are out of stock until mid-February 2021 (other formulations of granisetron (tablets and injection) are not affected). Specialist importer companies have indicated that unlicensed imports of granisetron 3.1mg/24hours...
Medicine Supply Notification: Normacol granules and Normacol Plus granules – Update
Update (14/01/2020): Normacol granules back in stock, Normacol Plus granules now expected early February 2021 Department of Health and Social Care (DHSC) has issued a medicine supply notification for Sterculia (Normacol) 62% w/w granules, Sterculia & Frangula Bark (Normacol Plus) 62%/8% w/w granules Normacol and Normacol Plus granules are out of stock until 13th September...
Medicine Supply Notification: Fluoxetine 30mg capsules (Advanz)
Update: (14/01/2020) resupply now expected End of March 2021 Department of Health and Social Care (DHSC) has today issued a medicine supply notification for Fluoxetine 30mg capsules (Advanz) Advanz, the sole supplier, are out of stock of fluoxetine 30mg capsules with resupply expected mid-December 2020 Fluoxetine 10mg and 20mg capsules remain available A Serious...
Medicine Supply Notification: Dulcolax (bisacodyl) 5mg and 10mg suppositories – Updated
Update (14/01/2021) – Due to changes in the availability of Bisacodyl suppositories – an updated overview can be found below: Product Supplier Current Stock Position Anticipated resupply date Bisacodyl 5mg suppositories Sanofi Out of stock Early March 2021 Bisacodyl 10mg suppositories Sanofi Out of stock Limited supplies expected early February 2021, full resupplies expected March...
Supply Disruption Alert: Prednisolone 5mg suppositories (RPH Pharmaceuticals) – Update
Update: 14/01/2021 Resupply date now expected to be End of January 2021 Department of Health and Social Care (DHSC) has issued a medicine supply notification for Prednisolone 5mg suppositories. Prednisolone 5mg suppositories are out of stock until end of July 2020 due to manufacturing issues. Unlicensed supplies of prednisolone 5mg suppositories have been sourced, lead...
DHSC flu vac stock: use for private patients
The Department of Health and Social Care (DHSC) has confirmed that from tomorrow (15th January 2021), community pharmacies can offer a flu vaccination using DHSC centrally procured vaccine to private patients or those within occupational health schemes (Group C patients in the DHSC guidance on use of centrally procured vaccines). This decision follows PSNC’s request...
PharmaTimes: PharmaTimes Website RSS
PharmaTimes - The latest news in healthcare and life sciences - PharmaTimes Website RSS
ViiV Healthcare continues HIV care partnership with Chelsea and Westminster Hospital
Partnership aims to transform HIV patient care with digital services
Xalkori bags FDA green light for rare paediatric non-Hodgkin lymphoma
Therapy approved for the treatment of paediatric patients with anaplastic large cell lymphoma
UK biotech Ixaka scores additional funding for cell and gene therapy research
Lead asset REX-001 is in Phase III development for chronic limb-threatening ischaemia
AZ, Daiichi Sankyo’s Enhertu wins US approval for HER2-positive gastric cancer
Approval is based on results from the Phase III DESTINY-Gastric01 trial
Boehringer Ingelheim and Enara Bio join forces to discover cancer immunotherapies
Agreement will leverage Enara's novel Dark Antigen discovery platform
Verona completes enrolment in pilot study of potential COVID-19 inhaler
Ensinfentrine is a first-in-class inhaled inhibitor of the enzymes phosphodiesterase 3 and 4
US breakthrough designation for ligelizumab in chronic spontaneous urticaria
In a Phase IIb trial, more patients experienced complete resolution of hives with ligelizumab compared to Xolair
NICE backs GSK’s Zejula in advanced ovarian cancer
Zejula has been recommended for use in newly diagnosed ovarian cancer patients
NHS England selects supermarket Asda to operate COVID-19 vaccination centre
Qualified pharmacists will administer the Pfizer/BioNTech vaccine at an in-store pharmacy
EU approval for ViiV’s Tivicay for children living with HIV
First dispersible tablet formulation of Tivicay now available for children in the EU
Valneva partners with Oxford Immunotec on T cell analysis for COVID-19 vaccine
Oxford Immunotec will perform T cell testing on participants receiving Valneva's vaccine candidate
Gilead and Vir unite to find a ‘functional cure’ for hepatitis B
Companies will collaborate on a combination therapy study
Roche’s Tecentriq/Avastin combo improves survival in liver cancer
Updated analysis is from the Phase III IMbrave150 study
Diurnal seeks marketing authorisation for Chronocort in the UK
MHRA submission is based on same application filed with the EMA
Eli Lilly announces mid-stage trial success for donanemab in Alzheimer’s
Investigational antibody targets a modified form of beta amyloid called N3pG
Every sector of the pharmaceutical market is represented under one roof, this year in Madrid. Attending CPhI Worldwide is the most cost effective way to establish new business relationships, meet with global partners and stay updated on the latest industry trends.
Find out more: https://www.cphi.com/europe/